Background and aims: Variations in inotrope changeover technique can contribute to deviations in blood pressure, heart rate, internal bleeding and in extremis, death (Sheppard, 2001; Crisp, 2002; ...

Against expectations, critically ill people in cardiogenic shock fared similarly receiving one widely used inotrope or another in the small DOREMI trial. Patients had the same clinical outcomes on ...

Reduction in the frequency of hospitalizations, by delaying additional episodes of acute decompensated heart failure; and Weaning patients with severe heart failure who are currently dependent on ...

One of the most frequently asked questions related to the use of these medications during rounds is whether there is a given drug or a combination of drugs that would effectively treat hypotension and ...

Toronto, ON - An investigational oral inotropic agent, a selective inhibitor of phosphodiesterase-3 (PDE-3), took a small, uncertain step forward when a randomized, placebo-controlled trial showed it ...